Jul 14, 2015
MDxHealth appointed Philip Ginsburg its chief medical officer. In his new role, he will be responsible for the firm's overall clinical strategy, including scientific and clinical affairs. Ginsburg has more than 20 years of experience in commercial medical laboratory and urology and was CMO at Toma Biosciences and Iris International, as well as president of Arista, the personalized medicine division of Iris, which was acquired by Beckman Coulter. He was also a co-founder, CEO and CMO of AlliedPath and served as senior medical director at Gen-Probe and medical director at Quest Diagnostics.